Björklund Pharma is an early-stage biopharmaceutical company with product candidates within the following therapeutic areas:

• Psychiatry
• Neurology
• Pain Management
• Sleep
• Ophthalmology
• Otolaryngology
• Oral Health
• Cardiology
• Pulmonology/Respiratory
• Gastrointestinal
• Renal/Hepatic
• Urology
• Hematology
• Oncology
• Endocrinology
• Dermatology
• Musculoskeletal Health and Bone Metabolism
• Allergy and Immunology
• Infectious Diseases
• Rare Diseases (Orphan Diseases)
• Pediatrics
• Women’s Health
• Men’s Health
• Geriatrics
• Toxicology
• Nutraceuticals
• Sports Performance and Recovery
• Regenerative Medicine

Most of the company’s product candidates are in the design, development, or early preclinical stages. Various tests and experiments are conducted during these phases to determine safety, effectiveness, and body metabolism. This information is used to design and plan clinical trials involving human subjects.